<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Grigore, I.</creatorName>
</creator>
<creator>
<creatorName>Diaconu, G.</creatorName>
</creator>
<creator>
<creatorName>Burlea, M.</creatorName>
</creator>
<creator>
<creatorName>Trandafir, L.</creatorName>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Opţiuni terapeutice ale spasticităţii la copii cu paralizie cerebrală</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2009</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1810-5289</relatedIdentifier>
<subjects>
<subject>cerebral palsy</subject>
<subject>spasticity</subject>
<subject>child</subject>
<subject>oral medication</subject>
<subject>surgical interventions</subject>
</subjects>
<dates>
<date dateType='Issued'>2009-07-01</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'>Cerebral palsy is one of the most common causes of activity limitation in children. Spasticity in children with CP is a serious problem. The objective of treatment in
spasticity are to optimize functional movement and prevent fixed deformity. Treatment methods including oral anti-spasticity medication, locally administered agent such as botulinum toxin or intrathecal administered agent such as baclofen and surgical interventions such as selective dorsal rhizotomy. There is not a standardized approach and the treatment needs to be adapted for the individual child.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>